Immunocompromising Medications
Patients who are actively taking immune-suppressing or modulating medications on the following (alphabetized) list compiled by UConn Health physicians may be eligible for a third dose of COVID-19 vaccine.
Please note that this list is instructive, and not intended to be all-inclusive of medications that may suppress or modulate the immune system.
Generic Name | Brand Name |
5-Fluorouracil | Carac |
Abatacept | Orencia |
Adalimumab | Humira |
Alemtuzumab | Campath |
Altretamine | Hexalen |
Anakinra | Kineret |
Atezolizumab | Tecentriq |
Avelumab | Bavencio |
Azathioprine | Imuran |
Baricitinib | Olumiant |
Basiliximab | Simulect |
Belatacept | Nulojix |
Bendamustine | Bendeka |
Bevacizumab | Avastin |
Busulfan | Myleran |
Carmustine | Gliadal Wafer |
Certolizumab pegol | Cimzia |
Cetuximab | Erbitux |
Chorambucil | Leukeran |
Cisplatin | Platinol |
cyclophosphamide | Nerosar |
Cyclosporine | Gengraf, Neoral, Sandimmune |
Cytarabine | Cytosar-U |
Dacarbazine | |
Dasatinib | Sprycel |
Dexamethasone ≥ 3 mg | |
Diaziquone | Progycem |
Dimethyl fumarate | Tecfidera |
Etanercept | Enbrel |
Everolimus | Zortress |
Fingolimod | Gilenya |
Gemcitabine | |
Glatiramer acetate | Copaxone |
Golimumab | Simponi |
Hydrocortisone ≥ 80 mg | |
Hydroxychloroquine | Plaquenil |
Ibritumomab tiuxetan | Zevalin |
Ibrutinib | Imbruvica |
ifosfamide | Ifex |
Imatinib mesylate | Gleevec, STI 571 |
Infliximab | Remicade |
Interferon alfa | Pegasys, PegIntron |
Interferon beta-1a | Avonex, Rebif |
Interferon beta-1b | Betaseron |
Ixekizumab | Taltz |
Lenalidomide | Revlimid |
Lomustine | Gleostine |
Mechorethamine | Valchlor |
Melphalan | Evomela |
Mercaptopurine | Purinethol |
Methotrexate | Otrexup, Trexall, Rasuvo |
Methylprednisolone ≥ 16 mg | |
Mitomycin C | |
Mycophenolate | CellCept |
Natalizumab | Tsabri |
Nivolumab | Opdivo |
Ofatumumab | Arzerra |
Oxaliplatin | Eloxatin |
Panitumumab | Vectibix |
Pembrolizumab | Keytruda |
Prednisolone ≥ 20 mg | |
Premetrexed | |
Procarbazine | Matulane |
Rilonacept | Arcalyst |
Rituximab | Rituxan |
Sarilumab | Kevzara |
Secukinumab | Cosentyx |
Sirolimus | Rapamune |
Streptozocin | Zanosar |
Sunitinib malate | Sutent |
Tacrolimus | Protopic, Envarsus XR |
Temozolomide | Temodar |
Thiotepa | Tepadina |
Tocilizumab | Actemra |
Tofacitinib | Xeljanz |
Trastuzumab | Herceptin |
Ustekinumab | Stelara |
Vedolizumab | Entyvio |